Who owns Journey Medical Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DERM from SEC Form 13F filings across 71 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 71 institutions disclosed 10.6M shares of Journey Medical Corp worth $75.2M — about 38.6% of shares outstanding; the largest disclosed holder is WASATCH ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
71
13F holders
$75.2M
value, 2026 filers
38.6%
of shares outstanding (10.6M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of DERM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | WASATCH ADVISORS LP | 2.9M | $20.2M | 0.1% | 10.4% | +34.0% |
| 2 | TANG CAPITAL MANAGEMENT LLC | 1.6M | $11.4M | 0.5% | 5.9% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 675,185 | $4.8M | 0.0% | 2.5% | -37.6% |
| 4 | PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.NEW | 536,000 | $3.8M | 0.2% | 1.9% | new |
| 5 | Pale Fire Capital SE | 528,584 | $3.7M | 0.3% | 1.9% | +9.7% |
| 6 | Opaleye Management Inc. | 350,000 | $2.5M | 0.2% | 1.3% | -63.5% |
| 7 | Summit Financial, LLC | 346,748 | $2.5M | 0.0% | 1.3% | -8.7% |
| 8 | JANE STREET GROUP, LLCNEW | 320,021 | $2.3M | 0.0% | 1.2% | new |
| 9 | Diametric Capital, LP | 295,663 | $2.1M | 0.2% | 1.1% | +50.5% |
| 10 | Ikarian Capital, LLC | 251,436 | $1.8M | 0.2% | 0.9% | 0.0% |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 229,700 | $1.6M | 0.0% | 0.8% | -5.3% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 216,004 | $1.5M | 0.0% | 0.8% | -53.4% |
| 13 | AMERICAN FINANCIAL GROUP INC | 180,000 | $1.3M | 0.4% | 0.7% | 0.0% |
| 14 | Trexquant Investment LP | 171,338 | $1.2M | 0.0% | 0.6% | +509.8% |
| 15 | MARSHALL WACE, LLPNEW | 139,843 | $990,087 | 0.0% | 0.5% | new |
| 16 | J. Goldman & Co LP | 137,584 | $974,095 | 0.0% | 0.5% | -72.5% |
| 17 | MILLENNIUM MANAGEMENT LLC | 110,016 | $778,913 | 0.0% | 0.4% | -71.3% |
| 18 | BlackRock, Inc. | 100,981 | $714,945 | 0.0% | 0.4% | -89.6% |
| 19 | XTX Topco Ltd | 100,923 | $714,535 | 0.0% | 0.4% | +243.7% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 94,729 | $670,681 | 0.0% | 0.3% | -31.2% |
| 21 | GOLDMAN SACHS GROUP INC | 90,294 | $639,282 | 0.0% | 0.3% | +30.1% |
| 22 | UBS Group AG | 83,514 | $591,279 | 0.0% | 0.3% | -78.6% |
| 23 | CITADEL ADVISORS LLCNEW | 82,149 | $581,615 | 0.0% | 0.3% | new |
| 24 | PVG ASSET MANAGEMENT CORPNEW | 79,573 | $563,377 | 0.3% | 0.3% | new |
| 25 | BOOTHBAY FUND MANAGEMENT, LLC | 67,442 | $477,489 | 0.0% | 0.2% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.